ELN risk stratification and outcomes in secondary and therapy-related AML patients consolidated with allogeneic stem cell transplantation

Secondary or therapy-related acute myeloid leukemia (s/tAML) differs biologically from de novo disease. In general s/tAML patients have inferior outcomes after chemotherapy, compared to de novo cases and often receive allogeneic stem cell transplantation (HSCT) for consolidation. The European Leukem...

Descripción completa

Detalles Bibliográficos
Autores principales: Jentzsch, Madlen, Grimm, Juliane, Bill, Marius, Brauer, Dominic, Backhaus, Donata, Goldmann, Karoline, Schulz, Julia, Niederwieser, Dietger, Platzbecker, Uwe, Schwind, Sebastian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035074/
https://www.ncbi.nlm.nih.gov/pubmed/33208914
http://dx.doi.org/10.1038/s41409-020-01129-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8035074/
https://www.ncbi.nlm.nih.gov/pubmed/33208914
http://dx.doi.org/10.1038/s41409-020-01129-1

Ejemplares similares